Developing an Opioid Taper Intervention Before Total Joint Arthroplasty
Recruiting now · Not applicable
Conditions studied: Arthritis Knee, Arthritis Hip, Chronic Pain
In brief
The goal of this clinical trial is to develop an pharmacist-led preoperative opioid taper intervention for patients undergoing total knee or hip replacement who are on chronic opioids before their surgery. The main questions it aims to answer are: * Is the intervention feasible and acceptable to patients? * Does the intervention result in a decrease in opioid dose during the preoperative period? Participants will meet with a clinical pharmacist, who will provide some basic education on pain and opioids, and will propose an opioid taper schedule. The pharmacist will then follow-up with the participant by phone each week until surgery to assess progress and adjust the taper as necessary.
Key facts
- Study ID
- NCT05788016
- Run by
- University of Alabama at Birmingham
- People needed
- 45
- Starts
- 2024-01-10
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-05-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- decided to pursue primary, unilateral total knee or hip arthroplasty with planned surgery date in 4-8 weeks
- currently taking between 20 and 90 MME of oral opioids, and that dose has been stable for at least 3 months
- have a reliable telephone number for contact
- speaks English
You may not qualify if…
- Taking opioid medications that include:
- Buprenorphine
- Methadone
- Long-acting formulations of opioid pain medications (e.g., extended-release oxycodone and extended-release morphine)
- Transdermal formations of opioid pain medications (e.g., fentanyl patches)
Where it is running
- UAB Hospital-Highlands — Birmingham, Alabama, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.